Home › Acute myeloïde leukemie › Oregon › Portland
Acute myeloïde leukemie klinische studies in Portland, OR
25 studies voor Acute myeloïde leukemie zoeken deelnemers op locaties in en rond Portland (binnen ongeveer 30 mijl). Open een studie om te zien wie er kan deelnemen en hoe je contact opneemt met het studieteam.
Officiële studietekst (Engels)
Rekruteren voor een studie? Laat deze bovenaan deze pagina verschijnen — $99 voor 30 dagen →
MYELOMATCH: A Screening Study to Assign People With Myeloid Cancer to a Treatment Study or Standard of Care Treatment Within myeloMATCH (MyeloMATCH Screening Trial)
RekruterenFase 2
- Providence Portland Medical Center, Portland
- Providence Saint Vincent Medical Center, Portland
Ruxolitinib With Azacitidine Maintenance for the Treatment of Patients With Acute Myeloid Leukemia Undergoing Reduced Intensity Allogeneic Stem Cell Transplantation
RekruterenFase 1
- OHSU Knight Cancer Institute, Portland
Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection
RekruterenObservatieonderzoekGezonde vrijwilligers welkom
- Providence Portland Medical Center, Portland
- Providence Saint Vincent Medical Center, Portland
- Providence Willamette Falls Medical Center, Oregon City · 12 mijl verwijderd
Comparing Cytarabine + Daunorubicin Therapy Versus Cytarabine + Daunorubicin + Venetoclax Versus Venetoclax + Azacitidine in Younger Patients With Intermediate Risk AML (A MyeloMATCH Treatment Trial)
RekruterenFase 2
- Providence Portland Medical Center, Portland
- Providence Saint Vincent Medical Center, Portland
A Study of Bleximenib, Venetoclax and Azacitidine For Treatment of Participants With Newly Diagnosed Acute Myeloid Leukemia (AML)
RekruterenFase 3
- Providence Portland Medical Center, Portland
- Providence Oncology and Hematology Care Clinic Westside, Portland
Ruxolitinib in Combination With Venetoclax With and Without Azacitidine in Treating Patients With Relapsed or Refractory Acute Myeloid Leukemia
RekruterenFase 1
- OHSU Knight Cancer Institute, Portland
Testing New Therapies for Patients With Acute Myeloid Leukemia Who Are Newly Diagnosed and Have Not Yet Started Treatment (A MyeloMATCH Treatment Trial)
RekruterenFase 2
- Providence Portland Medical Center, Portland
- Providence Saint Vincent Medical Center, Portland
Venetoclax and HMA Treatment of Older and Unfit Adults With FLT3 Mutated Acute Myeloid Leukemia (AML) (A MyeloMATCH Treatment Trial)
RekruterenFase 2
- Providence Portland Medical Center, Portland
- Providence Saint Vincent Medical Center, Portland
A Study to Compare Standard Chemotherapy to Therapy With CPX-351 and/or Gilteritinib for Patients With Newly Diagnosed AML With or Without FLT3 Mutations
RekruterenFase 3
- Legacy Emanuel Children's Hospital, Portland
- Oregon Health and Science University, Portland
Venetoclax in Combination With Cladribine and Cytarabine Alternating With Azacitidine Plus Venetoclax for the Treatment of Newly Diagnosed Monocytic AML and Active Signaling Mutated AML
RekruterenFase 2
- OHSU Knight Cancer Institute, Portland
A Study of Revumenib in R/R Leukemias Including Those With an MLL/KMT2A Gene Rearrangement or NPM1 Mutation
RekruterenFase 1/2
- Oregon Health & Science University, Portland
Ivosidenib and Venetoclax With or Without Azacitidine in Treating Patients With IDH1 Mutated Hematologic Malignancies
RekruterenFase 1/2
- Oregon Health and Science University, Portland
Revumenib in Combination With Azacitidine + Venetoclax in Patients NPM1-mutated or KMT2A-rearranged AML
RekruterenFase 3
- US-Portland OR-OHSU, Portland
The Pediatric Acute Leukemia (PedAL) Screening Trial - A Study to Test Bone Marrow and Blood in Children With Leukemia That Has Come Back After Treatment or Is Difficult to Treat - A Leukemia & Lymphoma Society and Children's Oncology Group Study
RekruterenFase 1/2
- Legacy Emanuel Children's Hospital, Portland
- Oregon Health and Science University, Portland
Venetoclax in Children With Relapsed Acute Myeloid Leukemia (AML)
RekruterenFase 3
- Doernbecher Children's Hospital, Portland
Mocravimod as Adjunctive and Maintenance Treatment in AML Patients Undergoing Allo-HCT
RekruterenFase 3
- Oregon Health & Science University (OHSU) - Knight Cancer Institute, Portland
Pemigatinib After Chemotherapy for the Treatment of Newly Diagnosed Acute Myeloid Leukemia
RekruterenFase 1
- OHSU Knight Cancer Institute, Portland
Induction and Consolidation With Fludarabine, Cytarabine, Idarubicin, and Venetoclax for the Treatment of Acute Myeloid Leukemia
RekruterenFase 2
- OHSU Knight Cancer Institute, Portland
Trial of Orca-T Following Reduced Intensity or Nonmyeloablative Conditioning in Patients With Acute Myeloid Leukemia or Myelodysplastic Syndrome
RekruterenFase 2
- Oregon Health and Science University, Portland
A Multicenter Access and Distribution Protocol for Unlicensed Cryopreserved Cord Blood Units (CBUs)
RekruterenObservatieonderzoek
- Oregon Health & Science University/Doernbecher Children's Hospital, Portland
Iadademstat in Combination With Azacitidine and Venetoclax in Treating Newly Diagnosed Acute Myeloid Leukemia
RekruterenFase 1
- OHSU Knight Cancer Institute, Portland
A Multi-phase Study of ASTX030 (Azacitidine and Cedazuridine) in Myeloid Neoplasm Alone or in Combination With Venetoclax in AML (AZTOUND Study)
RekruterenFase 2/3
- Oregon Health and Science University, Portland
A Platform Protocol to Investigate Post-Transplant Cyclophosphamide-Based Graft-Versus-Host Disease Prophylaxis in Patients With Hematologic Malignancies Undergoing Mismatched Unrelated Donor Peripheral Blood Stem Cell Transplantation
RekruterenFase 2
- Oregon Health & Science University, Portland
A Phase 1 Study of STX-0712 in Patients With Advanced Hematological Malignancies (CMML and AML)
RekruterenFase 1
- OHSU, Portland
Specialty Compared to Oncology Delivered Palliative Care for Patients With Acute Myeloid Leukemia
RekruterenGezonde vrijwilligers welkom
- Oregon Health & Science University, Portland
Acute myeloïde leukemie studies in andere steden
- Houston, TX85 studies
- New York City, NY51 studies
- Boston, MA44 studies
- Seattle, WA41 studies
- Baldwin Park, CA40 studies
- Columbus, OH35 studies
- Philadelphia, PA34 studies
- Durham, NC33 studies
- Atlanta, GA31 studies
- Tampa, FL29 studies
- Chicago, IL26 studies
- Washington, DC24 studies
Andere studies in Portland
- Niet-kleincellige longkanker46 studies
- Kanker (alle vormen)34 studies
- Borstkanker33 studies
- Prostaatkanker33 studies
- Metastatische kanker29 studies
- Colorectale kanker28 studies
- Eierstokkanker27 studies
- Longkanker26 studies
- Endometriumkanker24 studies
- Plaveiselcelcarcinoom van hoofd en hals19 studies
- Aldermeesklierkanker19 studies
- Hartfalen17 studies
Van ClinicalTrials.gov, gegevens opgehaald op 6 okt. 2026. Elke studie stelt eigen deelnamecriteria vast; het studieteam bepaalt wie er kan deelnemen.